Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2001, p. 478-484, Vol. 39, No. 2
Department of Medical Microbiology,
University Medical Center Nijmegen,1 and
Department of Medical Microbiology, Canisius Wilhelmina
Hospital,2 Nijmegen, The Netherlands
Received 14 August 2000/Returned for modification 21 September
2000/Accepted 31 October 2000
A microbroth kinetic model based on turbidity measurements was
developed in order to analyze the growth characteristics of three
species of filamentous fungi (Rhizopus microsporus, Aspergillus fumigatus, and Scedosporium prolificans)
characterized by different growth rates in five nutrient media
(antibiotic medium 3, yeast nitrogen base medium, Sabouraud broth, RPMI
1640 alone, and RPMI 1640 with 2% glucose). In general, five distinct
phases in the growth of filamentous fungi could be distinguished,
namely, the lag phase, the first transition period, the log phase, the
second transition period, and the stationary phase. The growth curves were smooth and were characterized by the presence of long transition periods. Among the different growth phases distinguished, the smallest
variability in growth rates among the strains of each species was found
during the log phase in all nutrient media. The different growth phases
of filamentous fungi were barely distinguishable in RPMI 1640, in which
the poorest growth was observed for all fungi even when the medium was
supplemented with 2% glucose. R. microsporus and A. fumigatus grew better in Sabouraud and yeast nitrogen base medium
than in RPMI 1640, with growth rates three to four times higher. None
of the media provided optimal growth of S. prolificans. The
germination of Rhizopus spores and Aspergillus and Scedosporium conidia commenced after 2 and 5 h of
incubation, respectively. The elongation rates ranged from 39.6 to
26.7, 25.4 to 20.2, and 16.9 to 9.9 µm/h for Rhizopus,
Aspergillus, and Scedoporium hyphae, respectively.
The germination of conidia and spores and the elongation rates of
hyphae were enhanced in antibiotic medium 3 and delayed in yeast
nitrogen base medium. In conclusion, the growth curves provide a useful
tool to gain insight into the growth characteristics of filamentous
fungi in different nutrient media and may help to optimize the
methodology for antifungal susceptibility testing.
In vitro susceptibility testing of
filamentous fungi is becoming increasingly important because of the
frequency and diversity of infections caused by them (24, 31,
37). In addition, more antifungal agents have been introduced
for clinical use and other new drugs are undergoing clinical
evaluation (34). Hence, standardized in vitro
susceptibility tests that give reproducible results, predict the
resistance of molds, and correlate with clinical outcome are required
(2, 3). Better inter- and intralaboratory agreement
has been achieved by standardizing various factors involved in testing
filamentous fungi for their susceptibilities such as the inoculum
preparation, the incubation conditions (time and temperature), the MIC
determination (reading time and end points), and the nutrient medium
(4, 5, 18, 27). The influence of medium on antifungal
susceptibility tests of yeasts is well established (3, 11, 15,
25, 28). Although there is no consensus as to the optimal
nutrient medium, by definition the nutrient medium must be able to
support adequate growth of the fungus without interfering with the
action of the antifungal agents and must result in reproducible results
that have clinical value (19). Many studies have shown
that synthetic medium RPMI 1640 gives reproducible results for the in
vitro testing of the susceptibility of yeasts to various antifungal
drugs (25, 28). This medium was also selected by the
Subcommittee for Antifungal Susceptibility Testing of the National
Committee for Clinical Laboratory Standards (NCCLS) for the in
vitro susceptibility testing of conidium-forming filamentous fungi
(23) although there was no evidence that this medium was
suitable for filamentous fungi (3). RPMI 1640 has a number
of advantages (28), but its suitability for the
susceptibility testing of nonfermentative yeasts such as
Cryptococcus neoformans has been questioned (10, 15,
33, 35). Therefore, the appropriateness of this medium for
filamentous fungi should not be implicitly postulated. Given the
greater variability in the growth rate, mechanisms of sporulation, and
nutrient requirements among the filamentous fungi than among yeasts,
growth characteristics of molds in relation to the medium should be
studied in detail. Due to the filamentous and non homogenous growth of
molds, the analysis of growth characteristics by growth curves is
difficult. In the present study we developed a microbroth kinetic
system in order to investigate the growth characteristics of
filamentous fungi in different nutrient media. Such a system would help
to select the medium that optimally supports the growth of these fungi
and to establish the optimal reading time of susceptibility testing of
filamentous fungi.
Isolates.
Fifteen clinical isolates of filamentous fungi
belonging to three species were selected based on their growth rates.
Rhizopus microsporus var. rhizopodiformis was
chosen as representative of fast-growing molds, Aspergillus
fumigatus was chosen as intermediate in growth rate, and
Scedosporium prolificans was chosen as representative of
slow-growing fungi. For each species five strains from our private
collection were tested: R. microsporus var.
rhizopodiformis, AZN190, AZN410, AZN5816, AZN5805, and
AZN1185; A. fumigatus, AZN9618, AZN9619,
AZN9620, AZN9621, and AZN9625; S. prolificans,
AZN7898, AZN7901, AZN7902, AZN7906, and AZN7918.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.478-484.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Analysis of Growth Characteristics of Filamentous
Fungi in Different Nutrient Media
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C and were revived
by subculturing onto Sabouraud glucose agar (SGA) tubes supplemented
with 0.5% chloramphenicol and incubated at 29°C for 7 days. The
isolates were subcultured again on SGA tubes and incubated for another
5 to 7 days at 37°C.
Nutrient media. The following five nutrient media were used: RPMI 1640 medium with L-glutamine but without bicarbonate (GIBCO BRL, Life Technologies, Woerden, The Netherlands) prepared alone (RPMI) or supplemented with 2% glucose (RPMI+); yeast nitrogen base (YNB; Difco Laboratories, Amsterdam, The Netherlands); antibiotic medium 3 (AM3; Oxoid, Hampshire, United Kingdom), and Sabouraud broth (SAB; Oxoid).
All media were prepared according to the manufacturer's instructions and buffered to pH 7.0 with 0.165 M morpholinepropanesulfonic acid (MOPS) (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). Double-strength media were prepared and sterilized by filtration (RPMI, RPMI+, and YNB) or by autoclavation (SAB and AM3).Growth curves. Conidia and spores were collected using a cotton swab from 7- to 10-day-old cultures and suspended in 0.1% Tween 80. The suspensions were adjusted to 2 × 104 spores/ml by counting the cells in a hemacytometer cell counting chamber. Viability was confirmed by plating serial dilutions on SGA plates. One hundred microliters of each suspension containing 0.1% Tween 80 was inoculated into 100 µl of double-strength medium in 96-well flat-bottom microtitration plates. Tween 80 was used in order to prevent the growth of fungi on the surfaces of the media inside the wells. The plates were sealed and incubated at 37°C for 100 h inside a plate reader (Rosys Anthos ht3; Anthos Labtec Instruments GmbH, Salzburg, Austria). The optical density (OD) at 405 nm was recorded for each well automatically every 15 min without shaking. The reader can detect changes of 0.001 in OD. Sequential OD measurements were used to generate growth curves for each fungus and medium in triplicate. All studies were conducted two times.
Microscopic examination.
In order to correlate OD changes
with the morphology of the fungi, conidia and spores were observed
microscopically in microtitration plates by a reverse microscope at
hourly intervals. At each time point, 100 conidia and spores were
counted and the percentage of germination in each medium was estimated
in triplicate. The lengths of hyphae formed by 15 germinated conidia or
spores were measured, and the average length was calculated in
triplicate. Furthermore, the change in hyphal length over time was
computed as (average length at t2
average length at
t1)/(t2
t1), where t1 and
t2 are the times at the beginning and end of the
measurement period, respectively. The mean elongation rate was
calculated by averaging the changes during sequential time periods of
the growth.
Kinetic parameters.
In order to compare the growth curves
for each species in the five different nutrient media, various
parameters were calculated based on the changes of the OD over time
using the MicroWin, version 3, software (Mikrotek Laborsysteme GmbH,
Overath, Germany). From the growth curve of each strain in each of the
media the following parameters were calculated: the highest OD
(ODmax), the average of all changes in OD (
OD) per
minute, where
OD = ODfinal
ODinitial in an interval of 15 min, and the maximal slope
(Smax), which was the largest increase rate in
OD repeated for 25 consecutive time points. Furthermore the following
time-related parameters were recorded: the time of first detectable OD
change, the time when 90% of the ODmax was reached
(OD90), and the time at which Smax
of the growth curve was reached.
rAUKC, were calculated for each time
point by subtracting the rAUKC for each time point from the corresponding rAUKC of the previous time point. The
rAUKC is an
estimate of changes in the slope of the growth curve and thus an
estimate of the growth rate of fungus. When the
rAUKC value increases linearly over time, the OD increases with a constant rate,
and when the
rAUKC value decreases or goes to zero over time, the
growth rate decreases or goes to zero, respectively. Thus, increasing
rAUKC values corresponded to high growth rates. The
rAUKC values
were used in order to distinguish different phases in the growth of
filamentous fungi and the time employed for each phase.
| |
RESULTS |
|---|
|
|
|---|
A total of 225 growth curves based on 90,000 time points were
obtained. The shapes of the growth curves were different depending on
the nutrient medium used and the species tested (Fig.
1A, 2A, and
3A). However they were very reproducible among the
replicates and the strains tested. Since the results of the two
experiments were similar, the data of the first experiment were used
for analysis.
|
|
|
The growth curves were fragmented and were analyzed. In general the
following phases in the growth of each of the tested genera could be
distinguished based on OD changes and
rAUKC values (Table 1). The first phase was the lag phase in
which no changes in OD were measured and the
rAUKC values were lower
than 5% of the maximal
rAUKC. Microscopic examination revealed that
during this phase germination of spores and conidia took place followed
by elongation of hyphae to a maximal length of 60 µm (Fig. 1D, 2D, and 3D). Further elongation of hyphae was detected
spectrophotometrically and resulted in a rapid increase in OD (first
transition period) until 30% of the maximal
rAUKC was reached.
After this phase, the
rAUKC increased and the growth curve reached
the maximal slope, the maximal
rAUKC (log phase). Afterwards a
second transition period, in which the slope of the growth curve
decreased continuously until the
rAUKC reached 70% of its maximum
and the OD tended to reach a plateau, was apparent (second transition
period). The last phase was the stationary phase, where no changes in
OD or negative slopes of the growth curve were observed and where
values for
rAUKC were lower than 70% of the maximum
rAUKC (Fig.
1A and B, 2A and B, and 3A and B).
|
R. microsporus.
The strains of R. microsporus var. rhizopodiformis showed the shortest
lag phase, with the first significant change in OD after 4.8 to
6.5 h of incubation at 37°C, and the OD90s for the five strains ranged between 20 and 40 h (Table
2). The OD90 was reached
earlier (after 20 h) when RPMI was used as the nutrient medium;
however in this medium the growth rate was very low, with an
ODmax of 0.29 and a slope of 0.61 × 10
4
(Table 2). Supplementation of RPMI with 2% glucose resulted in a
slight increase of the growth rate of the fungus. By contrast the
growth rates in SAB and YNB media were the highest, with
ODmaxs of 1.01 and 1.02 and slopes of 2.28 × 10
4 and 2.17 × 10
4, respectively. The
Smaxs in these media were observed after 15.75 and 18.60 h, respectively. After 66 h of incubation a decrease in
the OD was observed in AM3 but not in the other media (Fig. 1A). The
microscopical observations showed that the germination of spores
started after 2 h in AM3 and SAB, after 4 h in RPMI and
RPMI+, and after 5 h in YNB (Fig. 1C). The highest elongation rates of hyphae were observed in AM3 (39.6 µm/h), and the lowest were
observed in YNB (26.7 µm/h) (Fig. 1D). The highest rate of increase
in OD (
OD per minute) was observed during the log phase (0.5 to 3 times higher than those in the other growth phases (Table 1). Based on
the
rAUKC model the log phase was from 9 to 15.6 h in RMPI and
RPMI+, from 12 to 25.2 h in YNB, from 9 to 23.3 h in SAB, and
from 6.6 to 27 h in AM3 (Fig. 1B and Table 1). Based on
OD-per-minute values the lowest interstrain variation for all media
was found during the log phase. The mean variations ± standard
errors (SE) of
OD-per-minute values in the five media were 11% ± 2% for the log phase, 14% ± 1% for the first transition period,
33% ± 9% for the lag phase, 38% ± 9% for the second transition period, and 92% ± 26% for the stationary phase (Table 1).
|
A. fumigatus.
The first detectable growth for the
strains of A. fumigatus was after 9.65 h (Table 2)
although the germination of conidia was completed after 13 h (Fig.
2C). In Fig. 2A the differences in the shapes of the growth curves for
each nutrient medium are shown. The slopes of the growth curves in RPMI
medium, even when supplemented with 2% glucose, were fourfold lower
than those in SAB and YNB (Table 2). By contrast to that of
Rhizopus strains, the growth of the Aspergillus
strains failed to reach the stationary phase within 100 h.
Smax was reached after 30 h for all media except RPMI, in which Smax occurred after
17 h (Table 2). The germination of conidia started after 5 h
of incubation in all media although it was delayed for 1.5 h in
YNB (Fig. 2C). Similar rates of elongation of Aspergillus
hyphae occurred in all media (
25 µm/h) except in YNB, in which a
lower elongation rate (20.2 µm/h) was observed (Fig. 2D). The
OD-per-minute values in the log phase were higher than those in the
other growth phases except in RPMI, where the
OD per minute was
comparable to that in the first transition period. The log phase based
on
rAUKC values was between 14.4 and 46.8 h in RPMI and RPMI+,
between 24.6 and 56.4 h in SAB, between 30 and 65.4 h in YNB,
and between 16.2 and 54.6 h in AM3 (Fig. 2B and Table 1). The
lowest variation in
OD per minute among the five strains and among
the growth phases was found during the log phase. The mean
variations ± SE of
OD per minute in the five media were 9% ± 2% for the log phase, 15% ± 3% for the first transition period,
18% ± 3% for the second transition period, 22% ± 2% for the
stationary phase, and 23% ± 6% for the lag phase (Table 1).
S. prolificans.
The growth of this fungus was the
slowest among the species tested since after 100 h of incubation
the ODmax ranged from 0.27 in YNB to 0.64 in AM3 (Table 2).
The highest growth rate occurred in AM3, and the lowest occurred in
YNB, with slopes of the growth curves of 1.31 × 10
4
and 0.53 × 10
4, respectively. The
Smax in these media occurred after 40 and 26 h, respectively (Table 2). In all the nutrient media the fungus continued to grow until 100 h, except for YNB, in which the
plateau was reached within 50 h (Fig. 3A). The germination of
Scedosporium conidia started after 4 h of incubation in
AM3 and SAB, after 5 h of incubation in RPMI and RPMI+, and after
7 h of incubation in YNB, in which the delay in germination
increased during the incubation. Complete germination was not achieved
in any of the media after 20 h of incubation (Fig. 3C). The
elongation rates ranged from 16.9 to 9.9 µm/h, with the highest in
AM3 and the lowest in YNB (Fig. 3D). The
OD-per-minute values were
higher during the log phase but were comparable to those of the first transition period (Fig. 3B and Table 1). The log phase based on the
rAUKC model was between 17.4 and 49.8 h in RPMI and RPMI+, between 18 and 55.8 h in AM3, between 18.6 and 37.2 h in SAB, and between 21 and 41.3 h in YNB. The lowest interstrain variation was found during the log phase, with a mean ± SE of 14% ± 3%
compared with those during the first transition period (28% ± 5%),
the second transition period (39% ± 8%), the lag phase (44% ± 8%), and the stationary phase (82% ± 31%) (Table 1).
| |
DISCUSSION |
|---|
|
|
|---|
The nutrient medium is a major factor that influences the results of susceptibility tests (3, 30). According to clinical laboratory standards an optimal nutrient medium should provide good or adequate growth of the microorganisms (19). The relativity of this definition is clear since all the media tested here supported the growth of filamentous fungi to various degrees. Moreover the definition of an adequate medium is really a minimal requirement that has to be fulfilled in order for a medium to be considered as a candidate for the susceptibility tests. An optimal nutrient medium should provide not simply adequate growth but the best possible growth in order to allow molds to grow without restriction and express all phenotypes. Under these growth conditions, any failure of the fungus to grow in the presence of antifungal drugs should be considered as a true inability, i.e., lack of proper genetic predisposition to resist the antifungal drugs or interaction of the drug with the target.
The importance of the nutrient medium and the growth rate of the fungus in relation to in vitro susceptibility testing has been shown previously. The in vitro susceptibility of Candida albicans to fluconazole and miconazole depends on the stage of the growth of the fungus and the nutrient medium used (6, 17, 36). Yeasts in the exponential growth phase were more susceptible to fluconazole than those in the lag phase when they were cultivated in YNB-2% glucose medium (6, 17), and the in vitro activity of miconazole in CYG (0.5% casein gydrolase, 0.5% yeast extract, 0.5% glucose), NG (1% neopeptone, 0.5% glucose), and YNB-4% glucose media was greater when richer media were used (36). Differences in MICs for filamentous fungi were also observed when conidia (fungus in the lag phase) and hyphae (fungus in the log or stationary phase) were cultivated in RPMI 1640 (12). In another study where RPMI and YNB were employed the interaction between antimicrobial agents and fungi depended on the type of medium used (22).
The previous findings can be correlated with the results of this study. Figures 1A, 2A, and 3A show that RPMI poorly supports the growth of the three species of filamentous fungi tested. Supplementation with glucose essentially had little effect, despite being proposed as a means of improving the characteristics of this medium (32), and resulted only in a slight increase in the fungal growth even after incubation for 100 h. SAB and YNB were the more nutritious media and provided the highest growth for R. microsporus and A. fumigatus, with growth rates three to four times higher than those achieved in RPMI. None of the media supported the growth of S. prolificans sufficiently. Apparent were other effects of the media, such as the delay of germination of spores and conidia as well as the lower elongation rates of hyphae of all species in YNB medium, processes which were enhanced in AM3. By contrast with the growth of yeasts, where the stationary phase is reached within 30 h (15, 36), the growth of filamentous fungi is characterized by smoother curves and long transition periods although it depended on the medium and species. Interestingly, during the growth of R. microsporus in AM3, an OD decrease after 66 h of incubation, which could be correlated with the death phase of bacterial growth, occurred (20).
The use of a poor medium such as RPMI, in which fungi grow slowly, might result in erroneous MICs. In an extreme situation a fungus unable to grow in a certain medium would seem to be susceptible despite the fact that the inhibition of growth is not due to the action of the antifungal agent but due to the medium. There might be other situations, which are difficult to prove experimentally, in which a poor medium, although it supports fungal growth, acts synergistically with the drug in inhibiting growth, resulting in an appearance of better activity. The discrepancy in the interaction of a fluoroquinolone with amphotericin B against A. fumigatus in YNB (synergistic) and in RPMI (antagonistic) (22), as well as the higher activity of miconazole in richer media (36), could be explained by the growth curves. The high growth in YNB and the poor growth in RPMI correlate with different levels of metabolic activity. Thus, in YNB the drugs might penetrate better into the intracellular site of action in sufficient concentrations to exhibit an effect.
RPMI has been evaluated extensively for in vitro susceptibility testing of yeasts and has been shown to provide reproducible results (2, 25, 28, 30). Therefore, the NCCLS has proposed to use this medium as the standard medium for antifungal susceptibility testing of filamentous fungi (23). Like YNB, RPMI is a synthetic and completely defined medium and is characterized by small lot-to-lot variation, resulting in high reproducibility of susceptibility tests, unlike AM3, which has considerable variation from lot to lot and source to source. By contrast the use of chemically complex undefined media such as SAB medium is not recommended (19, 28) since undefined components that they may contain might interact with antifungal drugs (13, 14, 19, 26). Furthermore, acidic media such as YNB and SAB, if they were used unbuffered, may inactivate amphotericin B, which is not stable at low pH (16, 21).
Another important variable in susceptibility testing of filamentous fungi is the reading time. It is well known that prolonged incubation elevates the MICs of antifungal drugs (8, 29). The NCCLS addressed this by recommending different incubation periods for each species based on visual growth. Although the growth curves of filamentous fungi have not been previously studied in order to characterize the growth over time, the NCCLS recommended incubation periods of 24 h for the fast-growing species, usually belonging to the Zygomycetes, 72 h for the slow-growing species such as the black fungi, and 48 h for the other species (23).
In the field of antibacterial susceptibility testing, the MICs should be read when the growth control is in the log phase and not in the transition periods, i.e., between lag phase and log phase or between log phase and stationary phase, where unbalanced growth exists (20). Since the growth curves of filamentous fungi are characterized by long transition periods, the precise determination of these periods is a crucial parameter in order to obtain balanced growth. The same conclusion was made by Galgiani and Stevens (7) in terms of variability of MICs, when they observed that yeasts showed increased variation in the concentration of a drug producing 50% of the growth seen in a drug-free well when the MIC determination was made beyond 48 h of incubation. Beyond this incubation period, the drug-free culture reached the stationary phase and stopped growing resulting in higher variation in MICs (7). This effect is more obvious for fungistatic drugs since in the stationary phase the fungi in the drug-free control stop growing but those in drug-containing wells do not, which increases the difference in optical density between these two wells (unpublished observations). These findings could be correlated with our finding of high variation in the stationary phase compared with that in the other growth phases. That the growth phase is an important variable is supported by the findings that the inhibitory effects of ketoconazole and miconazole against C. albicans were indistinguishable when the yeasts were tested in the stationary phase (1).
Based on the results of this study (Table 1), the growth curves for
filamentous fungi during the transition periods were characterized by
rapid changes in slope and high variation compared with other parts of
the growth curve. The slopes in the transition periods were either
continuously decreasing until a plateau was reached (second transition
period) or increasing until the log phase was reached (first transition
period). Since the log phase is located between these two transition
periods, precise determination of these periods is required in order to
determine the boundaries of this growth phase. Due to long and smooth
transition periods of the growth curves of filamentous fungi, the
visualization of the start and end points of these periods by using the
OD changes is difficult. Therefore, a calculation model based on
rAUKC was developed. With the
rAUKC model even small changes of
the slopes, which might be an indication of transition between phases,
can be observed. The log phase of the growth curve is that part of the
curve where
rAUKC values increase linearly over time and the growth
rate is constant at its highest value. This model can be used to
describe the different growth phases of filamentous fungi and to
determine the boundaries of each phase. The level of 30% (increase
until 30% and decrease until 70%) of the maximal
rAUKC seems to be
the crucial breakpoint of the growth curves of filamentous fungi
indicating the presence of symmetry.
In summary, the above-mentioned studies indicate that during the log phase balanced growth takes place (20) and a greater distribution of MICs is obtained (1) and the reproducibility of MICs is higher (7) than in the other growth phases. In addition, this study shows that the lowest interstrain variation was observed during the log phase of the growth curve. Thus, the optimal reading time of antifungal susceptibility testing of filamentous fungi could be during the log phase. Therefore the precise knowledge of the growth phases during the growth of filamentous fungi would help to find the optimal reading time of the MICs.
Nevertheless, many factors are involved in the standardization of antifungal susceptibility testing. Unequivocally intercenter and intracenter reproducibility, as underlined by NCCLS, is a major issue for antifungal susceptibility testing of filamentous fungi. However another primary goal of susceptibility tests is the correlation of in vitro results with clinical response, and this does not favor necessarily and absolutely simplified methodologies. Although an ultimate challenge would be to find a common medium that would be suitable for as many fungi as possible, this study indicates that the standardization of susceptibility testing of filamentous fungi may require different nutrient media for each species and consequently different reading times of the MICs of antifungal drugs. Furthermore, findings for one species are not readily extrapolated to others, particularly for filamentous fungi, where significant morphological and physiological variations exist. Therefore, based on the results obtained from the growth curves further studies are required to investigate the effect of nutrient media and growth phases on MICs and ultimately to determine which approach correlates best with the clinical outcome.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by the EC-TMR-EUROFUNG network (ERBFMXR-CT970145) and by the Mycology Research Center of Nijmegen.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medical Microbiology, University Medical Center Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31-24-3614369. Fax: 31-24-3540216. E-mail: p.verweij{at}mmb.azn.nl.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Beggs, W.
1984.
Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.
Antimicrob. Agents Chemother.
25:316-318 |
| 2. |
Cormican, M. G., and M. A. Pfaller.
1996.
Standardization of antifungal susceptibility testing.
J. Antimicrob. Chemother.
38:561-578 |
| 3. | Espinel-Ingroff, A., F. Barchiesi, K. C. Hazen, J. V. Martinez-Suarez, and G. Scalise. 1998. Standardization of antifungal susceptibility testing and clinical relevance. Med. Mycol. 36(Suppl. 1):68-78. |
| 4. | Espinel-Ingroff, A., M. Bartlett, R. Bowden, N. X. Chin, C. Cooper, Jr., A. Fothergill, M. R. McGinnis, P. Menezes, S. A. Messer, P. W. Nelson, F. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143[Abstract]. |
| 5. |
Espinel-Ingroff, A.,
K. Dawson,
M. Pfaller,
E. Anaissie,
B. Breslin,
D. Dixon,
A. Fothergill,
V. Paetznick,
J. Peter,
M. G. Rinaldi, and T. Walsh.
1995.
Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.
Antimicrob. Agents Chemother.
39:314-319 |
| 6. | Gale, E. F., A. M. Johnson, D. Kerridge, and T. Y. Koh. 1975. Factors affecting the changes in amphotericin B sensitivity of Candida albicans during growth. J. Gen. Microbiol. 87:20-36[Medline]. |
| 7. |
Galgiani, J. N., and D. A. Stevens.
1976.
Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.
Antimicrob. Agents Chemother.
10:721-728 |
| 8. | Gehrt, A., J. Peter, P. A. Pizzo, and T. J. Walsh. 1995. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J. Clin. Microbiol. 33:1302-1307[Abstract]. |
| 9. | Ghannoum, M. A. 1997. Susceptibility testing of fungi and correlation with clinical outcome. J. Chemother. 9(Suppl. 1):19-24. |
| 10. |
Ghannoum, M. A.,
A. S. Ibrahim,
Y. Fu,
M. C. Shafiq,
J. E. Edwards, Jr., and R. S. Criddle.
1992.
Susceptibility testing of Cryptococcus neoformans: a microdilution technique.
J. Clin. Microbiol.
30:2881-2886 |
| 11. |
Ghannoum, M. A., and L. B. Rice.
1999.
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.
Clin. Microbiol. Rev.
12:501-517 |
| 12. | Guarro, J., C. Llop, C. Agular, and I. Pujol. 1997. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi. Antimicrob. Agents Chemother. 41:2760-2762[Abstract]. |
| 13. | Hoeprich, P. D., and P. D. Finn. 1972. Obfuscation of the activity of antifungal antimicrobics by culture media. J. Infect. Dis. 126:353-361[Medline]. |
| 14. | Hoeprich, P. D., and A. C. Huston. 1976. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J. Infect. Dis. 134:336-341[Medline]. |
| 15. |
Hoeprich, P. D., and J. M. Merry.
1986.
Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole.
J. Clin. Microbiol.
24:269-271 |
| 16. | Johnson, B., R. J. White, and G. M. Williamson. 1978. Factors influencing the susceptibility of Candida albicans to the polyenic antibiotics nystatin and amphotericin B. J. Gen. Microbiol. 104:325-333[Medline]. |
| 17. | Kerridge, D., T. Y. Koh, M. S. Marriott, and E. F. Gale. 1976. Microbiology and plant protoplasts, p. 23-28. In J. F. Peberdy, A. H. Rose, H. J. Rodger, and E. C. Cocking (ed.), Microbiology and plant protoplasts. Churchill Livingston, London, England. |
| 18. |
Llop, C.,
I. Pujol,
C. Aguilar,
J. Sala,
D. Riba, and J. Guarro.
2000.
Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods.
Antimicrob. Agents Chemother.
44:239-242 |
| 19. | McGinnis, M. R., and M. G. Rinaldi. 1991. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids, p. 198-251. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins, Baltimore, Md. |
| 20. | McGinnis, M. R., and M. G. Rinaldi. 1991. Determining the effects of antibiotics on bacterial growth by optical and electrical methods, p. 64-75. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins, Baltimore, Md. |
| 21. |
Minagawa, H.,
K. Kitaura, and N. Nakamizo.
1983.
Effects of pH on the activity of ketoconazole against Candida albicans.
Antimicrob. Agents Chemother.
23:105-107 |
| 22. | Nakajima, R., A. Kitamura, K. Someya, M. Tanaka, and K. Sato. 1995. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob. Agents Chemother. 39:1517-1521[Abstract]. |
| 23. | National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 24. | Perfect, J. R., and W. A. Schell. 1996. The new fungal opportunists are coming. Clin. Infect. Dis. 22(Suppl. 2):S112-S118. |
| 25. |
Pfaller, M. A.,
M. G. Rinaldi,
J. N. Galgiani,
M. S. Bartlett,
B. A. Body,
A. Espinel-Ingroff,
R. A. Fromtling,
G. S. Hall,
C. E. Hughes, and F. C. Odds.
1990.
Collaborative investigation of variables in susceptibility testing of yeasts.
Antimicrob. Agents Chemother.
34:1648-1654 |
| 26. | Polak, A., and H. J. Scholer. 1973. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments. Pathol. Microbiol. 39:148-159. |
| 27. | Pujol, I., J. Guarro, J. Sala, and M. D. Riba. 1997. Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B against Fusarium. Antimicrob. Agents Chemother. 41:808-811[Abstract]. |
| 28. |
Radetsky, M.,
R. C. Wheeler,
M. H. Roe, and J. K. Todd.
1986.
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
J. Clin. Microbiol.
24:600-606 |
| 29. | Reuben, A., E. Anaissie, P. E. Nelson, R. Hashem, C. Legrand, D. H. Ho, and G. P. Bodey. 1989. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob. Agents Chemother. 33:3290-3295. |
| 30. |
Rex, J. H.,
M. A. Pfaller,
M. G. Rinaldi,
A. Polak, and J. N. Galgiani.
1993.
Antifungal susceptibility testing.
Clin. Microbiol. Rev.
6:367-381 |
| 31. |
Richardson, M. D.
1991.
Opportunistic and pathogenic fungi.
J. Antimicrob. Chemother.
28(Suppl. A):1-11 |
| 32. |
Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez.
1995.
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
J. Antimicrob. Chemother.
35:739-749 |
| 33. |
Rodriguez-Tudela, J. L.,
F. Martin-Diez,
M. Cuenca-Estrella,
L. Rodero,
Y. Carpintero, and B. Gorgojo.
2000.
Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose.
Antimicrob. Agents Chemother.
44:400-404 |
| 34. |
Sheehan, D. J.,
C. A. Hitchcock, and C. M. Sibley.
1999.
Current and emerging azole antifungal agents.
Clin. Microbiol. Rev.
12:40-79 |
| 35. | St.-Germain, G., and C. Dion. 1996. Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans. Mycoses 39:201-206[Medline]. |
| 36. | van den Bossche, H., G. Willemsens, and J. M. van Cutsem. 1975. The action of miconazole on the growth of Candida albicans. Sabouraudia 13:63-73. |
| 37. | Vartivarian, S. E., E. J. Anaissie, and G. P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 17(Suppl. 2):S487-S491. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|